Last reviewed · How we verify
Combined with caspofungin
At a glance
| Generic name | Combined with caspofungin |
|---|---|
| Also known as | tacrolimus, methylprednisolone sodium succinate, mycophenolate sodium |
| Sponsor | LI YAN |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (PHASE3)
- Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics
- Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP (PHASE4)
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients (PHASE1, PHASE2)
- Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection (PHASE2)
- COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis (PHASE4)
- MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) (PHASE2)
- Antimicrobial PK in Infants With Suspected or Confirmed Infection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |